“…For example, although encouraged by the investigators not to do so, study PCPs may have discussed our treatment advice with each other. Still, the recovery rate of UC patients was similar to that experienced by the UC cohort in a report from Schulberg et al 47 Patients may also have seen a PCP on the date of the PRIME-MD who was not their usual PCP, may have switched providers within the group practice, or may have seen another PCP, who had been randomized to a different study condition, when their own PCP was unavailable (e.g., on vacation). However, we found that just 8% of study patients saw a PCP other than their usual provider on the date of the PRIME-MD's administration, and switching PCPs while remaining within the group practice was uncommon (<10%).…”